NCT02204046View on ClinicalTrials.gov

Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the Breast

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

February 28, 2001

Conditions
Adenocarcinoma
Interventions
DRUG

BIWA 4

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY